Innovation
1 patent family (1 granted) — focus: Human necessities; filing pace dormant. Cited 15 times.
| Year | Filings |
|---|---|
| 2012 | 1 |
| 2016 | 1 |
Investor mix
5 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 20% |
| Private equity | 4 | 80% |
Drugs for the treatment of stress urinary incontinence.
1 patent family (1 granted) — focus: Human necessities; filing pace dormant. Cited 15 times.
| Year | Filings |
|---|---|
| 2012 | 1 |
| 2016 | 1 |
5 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 20% |
| Private equity | 4 | 80% |